Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Trulieve Cannabis (TRLV) stock in plain English

Free brief · no signupStart here
TRLVPublished Nov 19, 2026
Trulieve Cannabis Corp
Healthcare · Drug Manufacturers - Specialty & Generic
Cultivates, processes, and dispenses medical and adult-use cannabis products through company-owned dispensaries.
Assets:
200+ retail dispensariesConcentrated primarily in Florida with locations in other states
4 million square feetCultivation and processing facilities across multiple operating markets
Proprietary product portfolioProduces branded flower, vapes, topicals, and edible formulations
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

58
OPS ScoreOperating finances
Latest quote
-6.69%$9.35
$1.80B
n/a (loss)
$1.08B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was TRLV. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Trulieve Cannabis (TRLV) do?

Trulieve Cannabis Corp (TRLV) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Cultivates, processes, and dispenses medical and adult-use cannabis products through company-owned dispensaries. Operates a vertically integrated cannabis business with a dominant retail dispensary footprint across Florida. It is worth $1.80B on the market and sold $1.08B over the last year.

Market cap
$1.80B
P/E ratio
None (reported a loss)
Annual sales
$1.08B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Brief updated
Nov 19, 2026

Brands and businesses behind TRLV

  • Muse: Produces cannabis concentrate extracts and vape cartridges sold through the company dispensary network.
  • Modern Flower: Sells mid-tier cannabis flower strains and pre-rolls directly to medical patients and adult-use consumers.
  • Sweet Talk: Produces cannabis-infused gummies, chocolates, and other confectionery products for retail dispensary sales.
  • Roll One: Offers budget-friendly cannabis flower and pre-rolls designed for cost-conscious retail shoppers.
  • Cultivar Collection: Offers craft-grown, hand-trimmed cannabis flower sold at a premium price point in retail stores.

TRLV’s flags, in plain English

Each flag is a number from Trulieve Cannabis’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Stupid Cash

Can pay this year's bills 5.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Still Climbing

Sales up 17.8% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Cheap on Cash Flow

Priced at 10.5 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Burning Cash

Losing money, profit margin of -41.2%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.

2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about TRLV

How big is Trulieve Cannabis?

Trulieve Cannabis’ market cap is $1.80B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.08B: what customers paid the company over the last year, before any costs.

What is TRLV’s P/E ratio?

TRLV has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with TRLV?

Federal cannabis prohibition restricts banking access, bars interstate shipments, and imposes punitive income tax treatment under Section 280E. That is one risk on Trulieve Cannabis’ card. Its first risk flag is Burning Cash, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Trulieve Cannabis’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TRLV’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card